Aardvark Therapeutics, Inc Common Stock
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -11 | -10 | -10 | |
EBITDA | -21,577 | -17,588 | -16,306 | -14,356 |
EBIT | -21,588 | -17,598 | -16,316 | -14,367 |
Net Income | -21,588 | -17,598 | -16,316 | -14,367 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -18,869 | -14,423 | -18,521 | -9,935 |
Cash | 62,436 | 47,051 | 39,285 | 25,998 |
Basic Shares | 21,815 | 21,815 | 21,745 | 21,693 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -36 | -16 | -97 | -110 |
EBITDA | -57,555 | -22,652 | -6,556 | -10,764 |
EBIT | -57,591 | -22,668 | -6,653 | -10,874 |
Net Income | -57,591 | -20,588 | -7,208 | -13,564 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -54,267 | -18,196 | -5,824 | -10,543 |
Cash | 47,051 | 61,641 | 9,735 | 15,559 |
Basic Shares | 21,815 | 21,695 | 21,384 | 21,384 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.99 |
2025-12-31 | -$0.81 |
2025-09-30 | -$0.75 |
2025-06-30 | -$0.66 |